CORTHealthcareMid-Cap
CORCEPT THERAPEUTICS INC Insider Trading Activity
Every SEC Form 4 insider transaction reported for CORCEPT THERAPEUTICS INC (CORT), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CORT insiders buying or selling?
CORCEPT THERAPEUTICS INC insiders reported 16 open-market buys ($17.0M) and 195 sells ($186.7M) across 211 Form 4 filings — a net selling position of $169.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 17, 2026)
Total Form 4 filings
211
SEC EDGAR
Insider filers
12
Insider buys (16)
$17.0M
Insider sells (195)
$186.7M
Insider sentiment
Net sellingNet insider flow of $169.7M in net selling.
Recent CORT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | James N Wilson | Director | Sale | 10.0K | $88.30 | $883.0K |
| Jul 17, 2026 | Atabak Mokari | Chief Financial Officer | Sale | 40.0K | $87.71 | $3.5M |
| Jul 8, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $93.13 | $1.9M |
| Jul 6, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 25.0K | $88.35 | $2.2M |
| Jun 18, 2026 | James N Wilson | Director | Sale | 10.0K | $83.20 | $832.0K |
| Jun 18, 2026 | David L Mahoney | Director | Sale | 20.0K | $84.53 | $1.7M |
| Jun 17, 2026 | Atabak Mokari | Chief Financial Officer | Sale | 40.0K | $81.15 | $3.2M |
| Jun 4, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $70.60 | $1.4M |
| Jun 3, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 25.0K | $70.21 | $1.8M |
| Jun 3, 2026 | Atabak Mokari | Chief Financial Officer | Sale | 40.0K | $70.00 | $2.8M |
| Jun 2, 2026 | BELANOFF JOSEPH K | Chief Executive Officer | Sale | 12.8K | $69.74 | $895.3K |
| May 29, 2026 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | Sale | 5.0K | $65.00 | $325.0K |
| May 29, 2026 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 75.0K | $65.59 | $4.9M |
| May 7, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $51.83 | $1.0M |
| May 5, 2026 | BELANOFF JOSEPH K | Chief Executive Officer | Sale | 40.0K | $50.10 | $2.0M |
| Apr 8, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $40.97 | $819.4K |
| Mar 27, 2026 | BELANOFF JOSEPH K | Chief Executive Officer | Sale | 26.2K | $50.07 | $1.3M |
| Mar 24, 2026 | William Guyer | Chief Development Officer | Sale | 11.8K | $36.01 | $423.7K |
| Mar 19, 2026 | BAKER G LEONARD JR | Director | Purchase | 100.0K | $33.14 | $3.3M |
| Mar 6, 2026 | William Guyer | Chief Development Officer | Sale | 8.2K | $35.99 | $296.3K |
| Feb 5, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $40.87 | $817.3K |
| Jan 9, 2026 | William Guyer | Chief Development Officer | Sale | 20.0K | $35.18 | $703.7K |
| Dec 4, 2025 | William Guyer | Chief Development Officer | Sale | 20.0K | $80.08 | $1.6M |
| Dec 4, 2025 | Sean Maduck | President, Corcept Endocrinology The power of attorney under which this form was signed is on file w | Sale | 20.0K | $79.52 | $1.6M |
| Dec 4, 2025 | Joseph Douglas Lyon | Chief Accounting & Technology Officer | Sale | 5.0K | $79.53 | $397.6K |
Showing the 25 most recent of 211 Form 4 filings for CORCEPT THERAPEUTICS INC.
Most active CORT insiders
- Sean Maduck39 filings
- Joseph Douglas Lyon35 filings
- Daniel N Swisher JR32 filings
- William Guyer30 filings
- Gary Charles Robb23 filings
Ask anything about CORT insider activity
Use Trabud's AI agent to query CORCEPT THERAPEUTICS INC's Form 4 history in plain English — "Show me CORT CEO purchases this year" or compare it against any other ticker.
Open the AI agentCORT insider trading FAQ
Are CORCEPT THERAPEUTICS INC insiders buying or selling?
Across 211 SEC Form 4 filings, CORCEPT THERAPEUTICS INC (CORT) insiders reported 16 open-market purchases totaling $17.0M and 195 sales totaling $186.7M. That is a net selling position of $169.7M.
How many insiders trade CORT stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for CORCEPT THERAPEUTICS INC. The most recent filing was accepted on Jul 17, 2026.
Where does Trabud get CORT insider trading data?
All CORT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.